Ogino A - Search Results

1

Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression.

Watanabe T, Katayama Y, Yoshino A, Yachi K, Ohta T, Ogino A, Komine C, Fukushima T. Watanabe T, et al. Among authors: ogino a. Brain Pathol. 2007 Jan;17(1):5-10. doi: 10.1111/j.1750-3639.2006.00030.x. Brain Pathol. 2007. PMID: 17493032 Free PMC article.

2

O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course.

Watanabe T, Katayama Y, Komine C, Yoshino A, Ogino A, Ohta T, Fukushima T. Watanabe T, et al. Among authors: ogino a. Int J Cancer. 2005 Feb 10;113(4):581-7. doi: 10.1002/ijc.20625. Int J Cancer. 2005. PMID: 15455376

3

Promoter hypermethylation of mismatch repair gene hMLH1 predicts the clinical response of malignant astrocytomas to nitrosourea.

Fukushima T, Katayama Y, Watanabe T, Yoshino A, Ogino A, Ohta T, Komine C. Fukushima T, et al. Among authors: ogino a. Clin Cancer Res. 2005 Feb 15;11(4):1539-44. doi: 10.1158/1078-0432.CCR-04-1625. Clin Cancer Res. 2005. PMID: 15746058

4

Preliminary individualized chemotherapy for malignant astrocytomas based on O6-methylguanine-deoxyribonucleic acid methyltransferase methylation analysis.

Watanabe T, Katayama Y, Ogino A, Ohta T, Yoshino A, Fukushima T. Watanabe T, et al. Among authors: ogino a. Neurol Med Chir (Tokyo). 2006 Aug;46(8):387-93; discussion 393-4. doi: 10.2176/nmc.46.387. Neurol Med Chir (Tokyo). 2006. PMID: 16936459 Free article.

5

Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas.

Ohta T, Watanabe T, Katayama Y, Yoshino A, Yachi K, Ogino A, Komine C, Fukushima T. Ohta T, et al. Among authors: ogino a. Oncol Rep. 2006 Nov;16(5):957-63. Oncol Rep. 2006. PMID: 17016577

6

Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas.

Yoshino A, Katayama Y, Ogino A, Watanabe T, Yachi K, Ohta T, Komine C, Yokoyama T, Fukushima T. Yoshino A, et al. Among authors: ogino a. J Neurooncol. 2007 Jun;83(2):153-62. doi: 10.1007/s11060-006-9316-9. Epub 2007 Jan 11. J Neurooncol. 2007. PMID: 17216555

7

Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.

Yachi K, Watanabe T, Ohta T, Fukushima T, Yoshino A, Ogino A, Katayama Y, Nagase H. Yachi K, et al. Among authors: ogino a. Int J Oncol. 2008 Sep;33(3):469-75. Int J Oncol. 2008. PMID: 18695875

8

The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.

Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C, Yokoyama T, Fukushima T. Ogino A, et al. J Neuropathol Exp Neurol. 2005 May;64(5):398-403. doi: 10.1093/jnen/64.5.398. J Neuropathol Exp Neurol. 2005. PMID: 15892297

9

Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.

Yoshino A, Katayama Y, Yokoyama T, Watanabe T, Ogino A, Ota T, Komine C, Fukushima T, Kusama K. Yoshino A, et al. Among authors: ogino a. J Neurooncol. 2005 Sep;74(3):249-60. doi: 10.1007/s11060-004-7316-1. J Neurooncol. 2005. PMID: 16187022

10

Effect of IFN-beta on human glioma cell lines with temozolomide resistance.

Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Naruse N, Sano E. Yoshino A, et al. Among authors: ogino a. Int J Oncol. 2009 Jul;35(1):139-48. doi: 10.3892/ijo_00000322. Int J Oncol. 2009. PMID: 19513561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters